Brain Derived Neurotrophic Factor: epigenetic regulation in psychiatric disorders

Brain Res. 2014 Oct 24:1586:162-72. doi: 10.1016/j.brainres.2014.06.037. Epub 2014 Sep 16.

Abstract

Brain Derived Neurotrophic Factor (BDNF) is a neurotrophin with important functions in neuronal development and neuroplasticity. Accumulating evidence suggests that alterations in BDNF expression levels underlie a variety of psychiatric and neurological disorders. Indeed, BDNF therapies are currently being investigated in animal models and clinical studies. However, very little is currently known about the mechanisms that deregulate BDNF gene expression in these disorders. The BDNF gene structure and tissue expression pattern is complex, controlled in humans by 9 different gene promoters. Recently, epigenetic changes at the BDNF gene locus have been proposed to provide a link between gene and environment. In this review, we will summarize the current knowledge of BDNF epigenetic regulation with respect to psychiatric disorders and describe how this information can be applied in therapy and future research.

Keywords: BDNF; Bipolar disorder; Borderline personality disorder; DNA methylation; Depression; Histone modifications; Neuronal plasticity; Schizophrenia.

Publication types

  • Review

MeSH terms

  • Animals
  • Brain-Derived Neurotrophic Factor / metabolism*
  • Epigenesis, Genetic*
  • Humans
  • Mental Disorders* / genetics
  • Mental Disorders* / metabolism
  • Mental Disorders* / physiopathology

Substances

  • Brain-Derived Neurotrophic Factor